Journal
HELIYON
Volume 7, Issue 9, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.heliyon.2021.e07994
Keywords
Lipid nanoparticles; Blood brain barrier (BBB); Solid lipid nanoparticles (SLN); Lipid nanocarriers (LNC); Glioblastoma
Categories
Ask authors/readers for more resources
Advancements in material science and bionanotechnology have driven the use of nanoparticles in healthcare to improve diagnosis, monitoring, and therapy. Lipid nanostructures play a crucial role in combating brain tumors, with research focusing on solid lipid nanoparticles and nanostructured lipid carriers for overcoming the blood brain barrier and increasing effectiveness.
Advancements in both material science and bionanotechnology are transforming the health care sector. To this end, nanoparticles are increasingly used to improve diagnosis, monitoring, and therapy. Huge research is being carried out to improve the design, efficiency, and performance of these nanoparticles. Nanoparticles are also considered as a major area of research and development to meet the essential requirements for use in nanomedicine where safety, compatibility, biodegradability, biodistribution, stability, and effectiveness are requirements towards the desired application. In this regard, lipids have been used in pharmaceuticals and medical formulations for a long time. The present work focuses on the use of lipid nanostructures to combat brain tumors. In addition, this review summarizes the literature pertaining to solid lipid nanoparticles (SLN) and nanostructured lipid carriers (LNC), methods of preparation and characterization, developments achieved to overcome blood brain barrier (BBB), and modifications used to increase their effectiveness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available